{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:57:26Z","timestamp":1781686646603,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Parathyroid hormone-related peptide (PTHrP) is a peptide hormone that shares structural similarity with parathyroid hormone (PTH) and binds to the same receptor, leading to increased calcium levels. Humoral hypercalcemia of malignancy (HHM) is typically mediated by tumor-derived PTHrP and accounts for the majority of cases of malignancy-associated hypercalcemia, whereas it is rarely observed in benign conditions. The purpose of this study was to systematically review the literature to map and provide a structured and transparent overview of reported cases of HHM in malignant gynecologic tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was conducted in PubMed\/MEDLINE and Web of Science, complemented by manual reference screening and additional searches using Google Scholar, identifying relevant articles published between 1973 and 2025. Clinical and biochemical characteristics were extracted and analyzed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 51 reported cases were identified, including 29 ovarian, 12 uterine, 5 vulvar, and 5 cervical tumors. Among the 29 cases in which serum PTHrP was measured, levels were elevated in 28 patients. In the remaining cases, suppressed PTH levels, exclusion of alternative causes, or indirect evidence from tissue immunohistochemistry (IHC) supported PTHrP involvement. Preoperative calcium levels ranged from 10.5 to 21.3\u00a0mg\/dL. Following tumor resection, both PTHrP and calcium levels declined and normalized in most patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that although rare, PTHrP-mediated hypercalcemia represents a clinically relevant paraneoplastic phenomenon in gynecologic malignancies. Prospective studies with standardized biochemical and tissue-based assessment are needed to clarify its epidemiology and clinical significance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08488-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:58:08Z","timestamp":1781683088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTHrP-associated hypercalcemia in gynecologic malignancies: a scoping review"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2806-3812","authenticated-orcid":false,"given":"Shara Maria","family":"Bohne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-6998","authenticated-orcid":false,"given":"Florian","family":"Wegwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-6094","authenticated-orcid":false,"given":"Judith","family":"Kruse-Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-1973","authenticated-orcid":false,"given":"Julia","family":"Gallwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-8060","authenticated-orcid":false,"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-6144","authenticated-orcid":false,"given":"Mir Fuad","family":"Hasanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"8488_CR1","doi-asserted-by":"publisher","DOI":"10.37029\/jcas.v10i2.675","volume":"10","author":"S Ashfaq","year":"2024","unstructured":"Ashfaq S, Shafiq W, Siddiqi AI et al (2024) Survival outcomes in malignancy-related hypercalcemia: a tertiary care single-center experience. J Cancer Allied Spec 10:675. https:\/\/doi.org\/10.37029\/jcas.v10i2.675","journal-title":"J Cancer Allied Spec"},{"key":"8488_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5603\/ep.108400","volume":"77","author":"E \u015eimdi","year":"2026","unstructured":"\u015eimdi E, Uzunlulu M, Eken E et al (2026) Hypercalcemia in hospitalized patients: prevalence, etiology and mortality predictors in a tertiary internal medicine ward. Endokrynol Pol 77:20\u201328. https:\/\/doi.org\/10.5603\/ep.108400","journal-title":"Endokrynol Pol"},{"key":"8488_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121051","volume":"13","author":"P Bartkiewicz","year":"2024","unstructured":"Bartkiewicz P, Kunachowicz D, Filipski M et al (2024) Hypercalcemia in cancer: Causes, effects, and treatment strategies. Cells 13:1051. https:\/\/doi.org\/10.3390\/cells13121051","journal-title":"Cells"},{"key":"8488_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/1947-2714.170600","volume":"7","author":"AE Mirrakhimov","year":"2015","unstructured":"Mirrakhimov AE (2015) Hypercalcemia of malignancy: An update on pathogenesis and management. N Am J Med Sci 7:483\u2013493. https:\/\/doi.org\/10.4103\/1947-2714.170600","journal-title":"N Am J Med Sci"},{"key":"8488_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1055\/a-1049-0647","volume":"51","author":"N Asonitis","year":"2019","unstructured":"Asonitis N, Angelousi A, Zafeiris C et al (2019) Diagnosis, pathophysiology and management of hypercalcemia in malignancy: A review of the literature. Horm Metab Res 51:770\u2013778. https:\/\/doi.org\/10.1055\/a-1049-0647","journal-title":"Horm Metab Res"},{"key":"8488_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000226209","volume":"32","author":"P Savvari","year":"2009","unstructured":"Savvari P, Peitsidis P, Alevizaki M et al (2009) Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie 32:517\u2013523. https:\/\/doi.org\/10.1159\/000226209","journal-title":"Onkologie"},{"key":"8488_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12659\/ajcr.900088","volume":"18","author":"V Motilal Nehru","year":"2017","unstructured":"Motilal Nehru V, Garcia G, Ding J et al (2017) Humoral hypercalcemia in uterine cancers: a case report and literature review. Am J Case Rep 18:22\u201325. https:\/\/doi.org\/10.12659\/ajcr.900088","journal-title":"Am J Case Rep"},{"key":"8488_CR8","doi-asserted-by":"publisher","first-page":"644303","DOI":"10.3389\/fonc.2021.644303","volume":"11","author":"CM Edwards","year":"2021","unstructured":"Edwards CM, Johnson RW (2021) From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression. Front Oncol 11:644303. https:\/\/doi.org\/10.3389\/fonc.2021.644303","journal-title":"Front Oncol"},{"key":"8488_CR9","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1210\/jc.2012-2142","volume":"97","author":"JJ Wysolmerski","year":"2012","unstructured":"Wysolmerski JJ (2012) Parathyroid hormone-related protein: An update. J Clin Endocrinol Metab 97:2947\u20132956. https:\/\/doi.org\/10.1210\/jc.2012-2142","journal-title":"J Clin Endocrinol Metab"},{"key":"8488_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.23750\/abm.v90i4.7715","volume":"90","author":"NB Lai","year":"2019","unstructured":"Lai NB, Martinez D (2019) Physiological roles of parathyroid hormone-related protein. Acta Biomed 90:510\u2013516. https:\/\/doi.org\/10.23750\/abm.v90i4.7715","journal-title":"Acta Biomed"},{"key":"8488_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.placenta.2003.08.001","volume":"25","author":"ME Wlodek","year":"2004","unstructured":"Wlodek ME, Di Nicolantonio R, Westcott KT et al (2004) PTH\/PTHrP receptor and mid-molecule PTHrP regulation of intrauterine PTHrP: PTH\/PTHrP receptor antagonism increases SHR fetal weight. Placenta 25:53\u201361. https:\/\/doi.org\/10.1016\/j.placenta.2003.08.001","journal-title":"Placenta"},{"key":"8488_CR12","first-page":"496","volume":"9","author":"KL Feldenzer","year":"2018","unstructured":"Feldenzer KL, Sarno J (2018) Hypercalcemia of malignancy. J Adv Pract Oncol 9:496\u2013504","journal-title":"J Adv Pract Oncol"},{"key":"8488_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.vh.2022.03.002","volume":"120","author":"A Grunbaum","year":"2022","unstructured":"Grunbaum A, Kremer R (2022) Parathyroid hormone-related protein (PTHrP) and malignancy. Vitam Horm 120:133\u2013177. https:\/\/doi.org\/10.1016\/bs.vh.2022.03.002","journal-title":"Vitam Horm"},{"key":"8488_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ijc.24471","volume":"125","author":"S Gagiannis","year":"2009","unstructured":"Gagiannis S, M\u00fcller M, Uhlemann S et al (2009) Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria. Int J Cancer 125:1551\u20131557. https:\/\/doi.org\/10.1002\/ijc.24471","journal-title":"Int J Cancer"},{"key":"8488_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1039490","volume":"14","author":"E Almuradova","year":"2023","unstructured":"Almuradova E, Cicin I (2023) Cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne) 14:1039490. https:\/\/doi.org\/10.3389\/fendo.2023.1039490","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8488_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/clinem\/dgac621","volume":"108","author":"G El-Hajj Fuleihan","year":"2023","unstructured":"El-Hajj Fuleihan G, Clines GA, Hu MI et al (2023) Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 108:507\u2013528. https:\/\/doi.org\/10.1210\/clinem\/dgac621","journal-title":"J Clin Endocrinol Metab"},{"key":"8488_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616","journal-title":"Int J Soc Res Methodol"},{"key":"8488_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK (2010) Scoping studies: advancing the methodology. Implement Sci 5:69. https:\/\/doi.org\/10.1186\/1748-5908-5-69","journal-title":"Implement Sci"},{"key":"8488_CR19","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-21-00242","author":"MDJ Peters","year":"2022","unstructured":"Peters MDJ, Godfrey C, McInerney P et al (2022) Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. https:\/\/doi.org\/10.11124\/JBIES-21-00242","journal-title":"JBI Evid Synth"},{"key":"8488_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4300\/JGME-D-22-00621.1","volume":"14","author":"S Mak","year":"2022","unstructured":"Mak S, Thomas A (2022) Steps for conducting a scoping review. J Grad Med Educ 14:565\u2013567. https:\/\/doi.org\/10.4300\/JGME-D-22-00621.1","journal-title":"J Grad Med Educ"},{"key":"8488_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"8488_CR22","first-page":"384","volume":"27","author":"TJ Wu","year":"1997","unstructured":"Wu TJ, Taylor RL, Kao PC (1997) Parathyroid-hormone-related peptide immunochemiluminometric assay. Developed with polyclonal antisera produced from a single animal. Ann Clin Lab Sci 27:384\u2013390","journal-title":"Ann Clin Lab Sci"},{"key":"8488_CR23","first-page":"569","volume":"57","author":"R Bilenchi","year":"2005","unstructured":"Bilenchi R, Poggiali S, Pisani C et al (2005) Malignant hypercalcemia in vulvar cancer. Minerva Ginecol 57:569\u2013574","journal-title":"Minerva Ginecol"},{"key":"8488_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/s0046-8177(97)90139-8","volume":"28","author":"R Kitazawa","year":"1997","unstructured":"Kitazawa R, Kitazawa S, Matui T, Maeda S (1997) In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma. Hum Pathol 28:379\u2013382. https:\/\/doi.org\/10.1016\/s0046-8177(97)90139-8","journal-title":"Hum Pathol"},{"key":"8488_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jjco\/hyi215","volume":"36","author":"Y Kinugasa","year":"2006","unstructured":"Kinugasa Y, Morishige K, Kamiura S et al (2006) Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma. Jpn J Clin Oncol 36:113\u2013115. https:\/\/doi.org\/10.1093\/jjco\/hyi215","journal-title":"Jpn J Clin Oncol"},{"key":"8488_CR26","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/1097-0142","volume":"70","author":"T Fujino","year":"1992","unstructured":"Fujino T, Watanabe T, Yamaguchi K et al (1992) The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer 70:2845\u20132850. https:\/\/doi.org\/10.1002\/1097-0142","journal-title":"Cancer"},{"issue":"1","key":"8488_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1447-0756.2006.00358.x","volume":"32","author":"N Suwaki","year":"2006","unstructured":"Suwaki N, Masuyama H, Mizutani Y et al (2006) Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma. J Obstet Gynaecol Res 32(1):94\u201398. https:\/\/doi.org\/10.1111\/j.1447-0756.2006.00358.x","journal-title":"J Obstet Gynaecol Res"},{"key":"8488_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0301-2115(98)00165-1","volume":"82","author":"M Koshiyama","year":"1999","unstructured":"Koshiyama M, Fujii H, Konishi M et al (1999) Recurrent clear cell carcinoma of the ovary changing into producing parathyroid hormone-related protein (PTH-rP) with hypercalcemia. Eur J Obstet Gynecol Reprod Biol 82:227\u2013229. https:\/\/doi.org\/10.1016\/s0301-2115(98)00165-1","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8488_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2169\/internalmedicine.3899-24","volume":"64","author":"T Ogino","year":"2025","unstructured":"Ogino T, Watanabe H, Yamazaki S et al (2025) Ectopic production of Parathyroid Hormone and production of Parathyroid Hormone-related Protein in dedifferentiated endometrial carcinoma induced severe hypercalcemia. Intern Med 64:1053\u20131059. https:\/\/doi.org\/10.2169\/internalmedicine.3899-24","journal-title":"Intern Med"},{"key":"8488_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/archpedi.156.1.83","volume":"156","author":"LM Schweiger","year":"2002","unstructured":"Schweiger LM, Hsiang HY (2002) Pathological case of the month. Acute symptomatic hypercalcemia associated with ovarian small cell carcinoma. Arch Pediatr Adolesc Med 156:83\u201384. https:\/\/doi.org\/10.1001\/archpedi.156.1.83","journal-title":"Arch Pediatr Adolesc Med"},{"key":"8488_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF03344128","volume":"29","author":"A Benit","year":"2006","unstructured":"Benit A, Allard J, Rimailho J et al (2006) Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels. J Endocrinol Invest 29:443\u2013449. https:\/\/doi.org\/10.1007\/BF03344128","journal-title":"J Endocrinol Invest"},{"key":"8488_CR32","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.5858\/2003-127-e181-APHPME","volume":"127","author":"S Tang","year":"2003","unstructured":"Tang S, Geevarghese S, Saab S et al (2003) A Parathyroid Hormone-Related Protein\u2013secreting metastatic epithelioid leiomyosarcoma. Arch Pathol Lab Med 127:e181\u2013e185. https:\/\/doi.org\/10.5858\/2003-127-e181-APHPME","journal-title":"Arch Pathol Lab Med"},{"key":"8488_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4021\/wjon2010.06.214w","volume":"1","author":"M Futagami","year":"2010","unstructured":"Futagami M, Yokoyama Y, Wakui M et al (2010) A case of ovarian clear cell carcinoma simultaneously producing Parathyroid Hormone-related Protein and Granulocyte Colony-Stimulating Factor. World J Oncol 1:138\u2013141. https:\/\/doi.org\/10.4021\/wjon2010.06.214w","journal-title":"World J Oncol"},{"key":"8488_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.31083\/j.ejgo.2020.05.5468","volume":"5","author":"J Yeom","year":"2020","unstructured":"Yeom J, Lee S, Kim Y (2020) Hypercalcemia associated with primary mucinous ovarian tumor followed by pseudomyxoma peritonei can be fatal: a case report. Eur J Gynaecol Oncol 5:10\u201331083. https:\/\/doi.org\/10.31083\/j.ejgo.2020.05.5468","journal-title":"Eur J Gynaecol Oncol"},{"key":"8488_CR35","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1210\/jc.2014-4250","volume":"100","author":"PJ Donovan","year":"2015","unstructured":"Donovan PJ, Achong N, Griffin K et al (2015) PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab 100:2024\u20132029. https:\/\/doi.org\/10.1210\/jc.2014-4250","journal-title":"J Clin Endocrinol Metab"},{"key":"8488_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.11005\/jbm.2017.24.4.249","volume":"24","author":"J Jin","year":"2017","unstructured":"Jin J, Chung JO, Chung MY et al (2017) Clinical characteristics, causes and survival in 115 cancer patients with parathyroid hormone related protein-mediated hypercalcemia. J Bone Metab 24:249\u2013255. https:\/\/doi.org\/10.11005\/jbm.2017.24.4.249","journal-title":"J Bone Metab"},{"key":"8488_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/cam4.270","volume":"3","author":"M Yao","year":"2014","unstructured":"Yao M, Murakami T, Shioi K et al (2014) Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas. Cancer Med 3:845\u2013854. https:\/\/doi.org\/10.1002\/cam4.270","journal-title":"Cancer Med"},{"key":"8488_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/JLP.JLP_117_18","volume":"11","author":"N Gupta","year":"2019","unstructured":"Gupta N, Yadav M, Gupta V et al (2019) Distribution of various histopathological types of ovarian tumors: A study of 212 cases from a tertiary care center of Eastern Uttar Pradesh. J Lab Physicians 11:75\u201381. https:\/\/doi.org\/10.4103\/JLP.JLP_117_18","journal-title":"J Lab Physicians"},{"key":"8488_CR39","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1172\/JCI46134","volume":"121","author":"J Li","year":"2011","unstructured":"Li J, Karaplis AC, Huang DC et al (2011) PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest 121:4655\u20134669. https:\/\/doi.org\/10.1172\/JCI46134","journal-title":"J Clin Invest"},{"key":"8488_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00241","volume":"9","author":"RW Johnson","year":"2018","unstructured":"Johnson RW, Sun Y, Ho PWM et al (2018) Parathyroid hormone-related protein negatively regulates tumor cell dormancy genes in a PTHR1\/Cyclic AMP-Independent manner. Front Endocrinol (Lausanne) 9:241. https:\/\/doi.org\/10.3389\/fendo.2018.00241","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8488_CR41","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncb3408","volume":"18","author":"RW Johnson","year":"2016","unstructured":"Johnson RW, Finger EC, Olcina MM et al (2016) Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol 18:1078\u20131089. https:\/\/doi.org\/10.1038\/ncb3408","journal-title":"Nat Cell Biol"},{"key":"8488_CR42","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-05-2814","volume":"66","author":"MA Henderson","year":"2006","unstructured":"Henderson MA, Danks JA, Slavin JL et al (2006) Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 66:2250\u20132256. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2814","journal-title":"Cancer Res"},{"key":"8488_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41591-025-04054-2","volume":"32","author":"M Abu-Remaileh","year":"2026","unstructured":"Abu-Remaileh M, Stransky LA, Bhalerao N et al (2026) Targeting of HIF2-driven cachexia in kidney cancer. Nat Med 32:245\u2013257. https:\/\/doi.org\/10.1038\/s41591-025-04054-2","journal-title":"Nat Med"},{"key":"8488_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molmed.2026.01.004","volume":"32","author":"J Yan","year":"2026","unstructured":"Yan J, Wang W, Wei G (2026) HIF2 drives PTHrP-mediated cancer cachexia. Trends Mol Med 32:199\u2013201. https:\/\/doi.org\/10.1016\/j.molmed.2026.01.004","journal-title":"Trends Mol Med"},{"key":"8488_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-0716-2565-1_33","volume":"2546","author":"MM Kushnir","year":"2022","unstructured":"Kushnir MM, Rockwood AL (2022) High sensitivity measurement of parathyroid hormone-related protein (PTHrP) in plasma by LC-MS\/MS. Methods Mol Biol 2546:375\u2013389. https:\/\/doi.org\/10.1007\/978-1-0716-2565-1_33","journal-title":"Methods Mol Biol"},{"key":"8488_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ijc.2910500511","volume":"50","author":"S Kitazawa","year":"1992","unstructured":"Kitazawa S, Kitazawa R, Fukase M et al (1992) Immunohistochemical evaluation of parathyroid hormone-related protein (PTHrP) in the uterine cervix. Int J Cancer 50:731\u2013735. https:\/\/doi.org\/10.1002\/ijc.2910500511","journal-title":"Int J Cancer"},{"key":"8488_CR47","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/1097-0142","volume":"73","author":"X Matias-Guiu","year":"1994","unstructured":"Matias-Guiu X, Prat J, Young RH et al (1994) Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study Cancer 73:1878\u20131881. https:\/\/doi.org\/10.1002\/1097-0142","journal-title":"An immunohistochemical study Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08488-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08488-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08488-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:20:17Z","timestamp":1781684417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08488-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8488"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08488-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"205"}}